SKI Market

A+| A| A-|

Indian Indices

Sensex

77,328.19 -516.33
( -0.66%)

Global Indices

Nasdaq

49,628.48 -303.12
(-0.61%)

Dow Jones

7,359.75 -26.37
(-0.36%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,228.01 -48.94
(-0.48%)

Forex

USD-INR

94.67 -0.51
(-0.53%)

EUR-INR

111.19 -0.10
(-0.09%)

GBP-INR

128.70 -0.19
(-0.14%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

100.85

440134.01

EPS(TTM)

Face Value()

Div & Yield %

18.19

0.87

Back

fynx capital ltd

Sandur Manganese & Iron Ores consolidated net profit declines 15.74% in the December 2025 quarter

Feb 05,2026

Net profit of Sandur Manganese & Iron Ores declined 15.74% to Rs 115.71 crore in the quarter ended December 2025 as against Rs 137.33 crore during the previous quarter ended December 2024. Sales rose 27.05% to Rs 1209.31 crore in the quarter ended December 2025 as against Rs 951.87 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1209.31	951.87	27
OPM %	20.73	25.24	-
PBDT	232.41	218.77	6
PBT	178.81	180.42	-1
NP	115.71	137.33	-16

77,328.19 -516.33 ( -0.66%)

49,628.48 -303.12 (-0.61%)

7,359.75 -26.37 (-0.36%)

62,681.30 -152.54 (-0.24%)

10,228.01 -48.94 (-0.48%)

94.67 -0.51 (-0.53%)

111.19 -0.10 (-0.09%)

128.70 -0.19 (-0.14%)

0.60 0.00 (0.12%)